Our top pick for
City Office REIT Inc is a reit-office business based in the US. City Office REIT shares (CIO) are listed on the NYSE and all prices are listed in US Dollars. City Office REIT employs 20 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$19.16|
|52-week range||$5.82 - $19.21|
|50-day moving average||$17.88|
|200-day moving average||$13.73|
|Wall St. target price||$18.67|
|Dividend yield||$0.6 (3.16%)|
|Earnings per share (TTM)||$1.06|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-20)||1.11%|
|1 month (2021-09-27)||7.88%|
|3 months (2021-07-27)||47.73%|
|6 months (2021-04-27)||74.50%|
|1 year (2020-10-27)||191.63%|
|2 years (2019-10-25)||42.99%|
|3 years (2018-10-26)||69.71%|
|5 years (2016-10-27)||53.04%|
Valuing City Office REIT stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of City Office REIT's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
City Office REIT's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, City Office REIT shares trade at around 18x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
City Office REIT's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $92 million.
The EBITDA is a measure of a City Office REIT's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$160.6 million|
|Operating margin TTM||19.91%|
|Gross profit TTM||$102.5 million|
|Return on assets TTM||1.71%|
|Return on equity TTM||12.16%|
|Market capitalisation||$830.1 million|
TTM: trailing 12 months
There are currently 786,064 City Office REIT shares held short by investors – that's known as City Office REIT's "short interest". This figure is 73.9% up from 452,141 last month.
There are a few different ways that this level of interest in shorting City Office REIT shares can be evaluated.
City Office REIT's "short interest ratio" (SIR) is the quantity of City Office REIT shares currently shorted divided by the average quantity of City Office REIT shares traded daily (recently around 649639.66942149). City Office REIT's SIR currently stands at 1.21. In other words for every 100,000 City Office REIT shares traded daily on the market, roughly 1210 shares are currently held short.
However City Office REIT's short interest can also be evaluated against the total number of City Office REIT shares, or, against the total number of tradable City Office REIT shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case City Office REIT's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 City Office REIT shares in existence, roughly 20 shares are currently held short) or 0.0236% of the tradable shares (for every 100,000 tradable City Office REIT shares, roughly 24 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against City Office REIT.
Find out more about how you can short City Office REIT stock.
Dividend payout ratio: 44.44% of net profits
Recently City Office REIT has paid out, on average, around 44.44% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.15% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), City Office REIT shareholders could enjoy a 3.15% return on their shares, in the form of dividend payments. In City Office REIT's case, that would currently equate to about $0.6 per share.
While City Office REIT's payout ratio might seem fairly standard, it's worth remembering that City Office REIT may be investing much of the rest of its net profits in future growth.
City Office REIT's most recent dividend payout was on 21 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 6 October 2021 (the "ex-dividend date").
Over the last 12 months, City Office REIT's shares have ranged in value from as little as $5.8248 up to $19.21. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while City Office REIT's is 1.5159. This would suggest that City Office REIT's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
City Office REIT, Inc. (NYSE: CIO) invests in high-quality office properties in 18-hour cities with strong economic fundamentals, primarily in the Southern and Western United States. At September 30, 2020, CIO owned office complexes comprising 5. 8 million square feet of net rentable area (?NRA?). .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.